Innovent Biologics and Sanegene Bio USA have entered a collaboration to co-develop SGB-3908, an siRNA drug candidate targeting angiotensinogen (AGT) for hypertension treatment. SGB-3908, an IND-e...
GC Biopharma, in collaboration with the Korea Disease Control and Prevention Agency (KDCA), has submitted "GC1109" for marketing approval to the Korean Ministry of Food and Drug Safety (MFDS). Th...
Ascentage Pharma, a global biopharmaceutical company focused on developing innovative treatments for cancer, chronic hepatitis B (CHB), and age-related diseases, has announced a significant clini...
DelNova has announced a strategic partnership with Pace® Life Sciences to serve as their contract development and manufacturing organization (CDMO). This collaboration is aimed at advancing D...
Biopharmaceutical impurities can be divided into two categories: extraneous contaminants and product-related impurities. Extraneous contaminants include microbial contamination, pyrogens, cellula...
